99-8199. Mutual Recognition of Pharmaceutical Good Manufacturing Practice Inspection Reports, Medical Device Quality System Audit Reports, and Certain Medical Device Product Evaluation Reports Between the United States and the European Community; ...  

  • [Federal Register Volume 64, Number 64 (Monday, April 5, 1999)]
    [Rules and Regulations]
    [Pages 16347-16348]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 99-8199]
    
    
    =======================================================================
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    21 CFR Part 26
    
    [Docket No. 98N-0185]
    RIN 0910-ZA11
    
    
    Mutual Recognition of Pharmaceutical Good Manufacturing Practice 
    Inspection Reports, Medical Device Quality System Audit Reports, and 
    Certain Medical Device Product Evaluation Reports Between the United 
    States and the European Community; Correction
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Final rule; correction.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is correcting a final 
    rule that appeared in the Federal Register of November 6, 1998 (63 FR 
    60122). The document amended FDA's regulations under an international 
    agreement between the United States and the European Community. FDA 
    took this action to enhance its ability to ensure the safety and 
    effectiveness of pharmaceuticals and medical devices through more 
    efficient utilization of its regulatory resources. The document was 
    published with some inadvertent errors. This document corrects those 
    errors.
    
    EFFECTIVE DATE: March 31, 1999.
    
    FOR FURTHER INFORMATION CONTACT: Merton V. Smith, Office of 
    International
    
    [[Page 16348]]
    
    Affairs (HFG-1), Office of External Affairs, Food and Drug 
    Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-0910, 
    or e-mail ``MSmith@oc.fda.gov''.
    SUPPLEMENTARY INFORMATION: In FR Doc. 98-29609, appearing on page 
    60122, in the Federal Register of Friday, November 6, 1998, the 
    following corrections are made:
        1. In the preamble, on page 60137, in the third column, in the 
    fifth paragraph, in the third line, after ``to the following:'', ``that 
    only'' is removed.
    
    
    Sec. 26.1  [Corrected]
    
        2. On page 60142, in the first column, in Sec. 26.1(c), in the 
    fourth line, ``that only'' is removed.
    
    
    Sec. 26.50  [Corrected]
    
        3. On page 60153, in Appendix B of subpart B in Sec. 26.50, in 
    Table 2, in the first column, under the subheading ``Clinical 
    Thermometers:'', the third entry beginning with ``AN 868.5925 * * *'' 
    is removed; in that same table, under the subheading ``Hypodermic 
    Needles and Syringes (except anti-stick and self-destruct):'', the 
    third entry beginning with ``OR 888.3020 * * * is removed; and in that 
    same table, the subheading ``External Fixators (except devices with no 
    external components):'' and the two entries that follow are removed.
    
        Dated: March 30, 1999.
    William K. Hubbard,
    Acting Deputy Commissioner for Policy.
    [FR Doc. 99-8199 Filed 3-31-99; 11:57 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Effective Date:
3/31/1999
Published:
04/05/1999
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Final rule; correction.
Document Number:
99-8199
Dates:
March 31, 1999.
Pages:
16347-16348 (2 pages)
Docket Numbers:
Docket No. 98N-0185
RINs:
0910-ZA11
PDF File:
99-8199.pdf
CFR: (2)
21 CFR 26.1
21 CFR 26.50